Koch disease (Tuberculosis of bone) - Symptoms, Causes, Treatment & Prevention

Although TB can affect anyone, skeletal TB is more prevalent in:

• Adults aged 20‑40 years (peak incidence during the active, working years).
• People with compromised immune systems – HIV co‑infection, diabetes, chronic kidney disease, or those on immunosuppressive therapy.
• Individuals living in or emigrating from high‑TB‑burden countries (India, China, South‑Africa, Indonesia, Philippines).
• Patients with a history of untreated or inadequately treated pulmonary TB.

Globally, the World Health Organization (WHO) estimated 10 million new TB cases in 2023, and of those, approximately 0.2 million (2 %) presented with extrapulmonary disease, a fraction of which involved bone and joints.^[1]

Symptoms

Symptoms develop slowly, often over months, and may mimic other musculoskeletal disorders. The most common clinical picture includes:

General (systemic) symptoms

• Fever – low‑grade, intermittent, often worse in the late afternoon or at night.
• Night sweats – soaking the sheets despite a cool room.
• Weight loss & anorexia – unintended loss of >5 % body weight.
• Fatigue & malaise – generalized sense of being unwell.

Local (skeletal) symptoms

• Pain – dull, progressive, and often localized to the affected bone or joint; pain may worsen with movement.
• Swelling – palpable mass or fullness over the joint, sometimes with overlying skin redness.
• Limited range of motion – stiffness, especially in weight‑bearing joints (hip, knee).
• Deformity – especially in spinal TB where vertebral collapse can cause kyphosis (“gibbus”).
• Cold abscess – a fluctuant, non‑florid collection of pus that feels cold to the touch; common in the thoracic spine.
• Neurological deficits – compression of spinal cord or nerve roots may produce numbness, tingling, or weakness in the limbs.

Because onset is insidious, many patients first attribute symptoms to sports injuries, arthritis, or disc disease, delaying diagnosis by several months.

Causes and Risk Factors

Pathogenesis

Skeletal TB results from hematogenous spread of M. tuberculosis from a primary focus, usually the lungs, to the cancellous bone or synovium. The bacterium thrives in the low‑oxygen environment of bone marrow, forming granulomas that erode bone and cartilage.

Key Risk Factors

• HIV infection – increases risk of extrapulmonary TB by 15‑20 times.^[2]
• Diabetes mellitus – impairs macrophage function, raising TB susceptibility.
• Malnutrition – low body‑mass index (<18 kg/m²) correlates with higher extrapulmonary disease rates.
• Immunosuppressive drugs – corticosteroids, TNF‑α inhibitors (e.g., infliximab), or chemotherapy.
• Previous TB exposure – untreated or inadequately treated pulmonary TB leaves dormant bacilli that can reactivate.
• Living/working in congregate settings – prisons, shelters, or long‑term care facilities.
• Age extremes – children and the elderly have weaker cell‑mediated immunity.

Diagnosis

Diagnosing bone TB requires a combination of clinical suspicion, imaging, microbiology, and histopathology.

1. Medical History & Physical Examination

Clinicians look for the classic systemic TB symptoms, a history of prior TB, exposure risk, and focal tenderness or deformity.

2. Imaging Studies

• Plain radiographs (X‑ray) – early stages may be normal; later show osteolysis, vertebral collapse, or joint space narrowing.
• Magnetic Resonance Imaging (MRI) – gold standard for early detection; highlights marrow edema, abscess formation, and spinal cord compression.
• Computed Tomography (CT) scan – useful for detailed bony architecture and surgical planning.
• Bone scan (technetium‑99m) – detects increased osteoblastic activity, helpful when disease is multifocal.

3. Laboratory Tests

• Complete blood count (CBC) – may show mild anemia or leukocytosis.
• Erythrocyte sedimentation rate (ESR) & C‑reactive protein (CRP) – typically elevated, reflecting inflammation.
• Tuberculin skin test (TST) or Interferon‑γ Release Assays (IGRA) – indicate latent TB infection but do not confirm skeletal disease.

4. Microbiological Confirmation

• Acid‑fast bacilli (AFB) smear of aspirated pus or tissue – rapid but low sensitivity.
• Mycobacterial culture – gold standard, takes 2‑8 weeks; allows drug‑susceptibility testing.
• Polymerase chain reaction (PCR)/GeneXpert MTB/RIF – detects DNA and rifampicin resistance within hours; increasingly used on tissue specimens.

5. Histopathology

Biopsy of bone or synovial tissue shows caseating granulomas with Langhans giant cells – characteristic, though not exclusive, for TB.

**Diagnosis is usually confirmed when at least two of the following are present:** imaging compatible with TB, microbiological evidence (AFB, culture, or PCR), and histopathology showing granulomatous inflammation, all in the context of compatible clinical features.

Treatment Options

Management combines prolonged antimicrobial therapy with surgical intervention when necessary.

1. Pharmacologic Therapy

Current WHO‑endorsed regimens for drug‑sensitive skeletal TB are 6 months of first‑line therapy, extended to 9–12 months for complex disease.

**Key points:**
• Directly observed therapy (DOT) improves adherence.
• Baseline liver function tests and visual acuity (for ethambutol) are mandatory.
• For drug‑resistant TB, individualized regimens based on susceptibility testing (often 9–20 months) are required, using fluoroquinolones, linezolid, bedaquiline, etc.^[3]

2. Surgical Management

• Debridement & drainage – removal of necrotic bone and abscesses to reduce bacterial load.
• Stabilization – instrumentation (rods, screws) for spinal instability or severe deformity.
• Joint reconstruction – arthroplasty for advanced hip/knee involvement after infection control.
• Percutaneous aspiration – minimally invasive drainage of cold abscesses under imaging guidance.

Surgery is indicated when there is neurological compromise, severe deformity, failure of medical therapy, or large abscesses that threaten vital structures.

3. Adjunctive Measures

• Immobilization – braces or orthotics to limit motion and promote healing.
• Nutrition support – high‑protein, calorie‑dense diet to counteract catabolism.
• Physiotherapy – early gentle range‑of‑motion exercises after acute inflammation subsides to prevent joint stiffness.
• Vitamin D supplementation – may enhance antimicrobial immunity; discuss dosing with a physician.

Living with Koch Disease (Tuberculosis of Bone)

Even after the infection is controlled, patients often need to adapt daily routines to protect their musculoskeletal health.

Medication Adherence

• Set daily alarms or use a pillbox.
• Attend all scheduled DOT visits; inform the health team of any side‑effects promptly.
• Never stop drugs early, even if you feel better.

Physical Activity

• Follow physiotherapy prescriptions – start with low‑impact activities (walking, swimming) and progress as advised.
• Avoid high‑impact sports or heavy lifting until imaging confirms bone healing.
• Use ergonomic supports (lumbar corset, joint braces) when standing or carrying loads.

Nutrition & Lifestyle

• Consume 1.5–2 g protein per kg body weight daily (lean meats, legumes, dairy).
• Maintain adequate vitamin D (800–1000 IU/day) and calcium (1000 mg/day) intake.
• Quit smoking – tobacco impairs bone healing and increases relapse risk.
• Limit alcohol, which can exacerbate liver toxicity from anti‑TB drugs.

Regular Follow‑Up

Schedule clinic visits every 1–2 months during treatment for clinical review, liver function tests, and repeat imaging (typically MRI at 3‑month intervals). Document any new pain, swelling, or neuro‑deficits.

Prevention

• Vaccination – Bacillus Calmette‑Guérin (BCG) vaccine offers partial protection against disseminated TB, especially in infants.
• Screening high‑risk groups – HIV‑positive patients, diabetics, and close contacts of TB cases should undergo annual symptom review and IGRA/TST testing.
• Prompt treatment of pulmonary TB – reduces hematogenous spread to bone.
• Infection control – adequate ventilation, mask use in congregate settings, and cough etiquette.
• Nutrition and general health – balanced diet, regular exercise, and management of chronic diseases lower susceptibility.

Complications

If left untreated or inadequately treated, skeletal TB can lead to serious, sometimes irreversible damage.

• Spinal deformity (gibbus) – kyphotic curvature that may impair pulmonary function.
• Neurological impairment – permanent paralysis or sensory loss from spinal cord compression.
• Joint destruction – severe osteoarthritic changes requiring joint replacement.
• Chronic sinus or draining fistula – persistent external drainage from abscess cavities.
• Secondary bacterial infection – superinfection of necrotic tissue.
• Drug resistance – incomplete therapy can select for multidrug‑resistant TB (MDR‑TB), complicating future treatment.
• Systemic sequelae – malnutrition, cachexia, and psychosocial impact due to prolonged disability.

When to Seek Emergency Care

References:

1. World Health Organization. Global Tuberculosis Report 2023. https://www.who.int/publications/i/item/9789240067979
2. Centers for Disease Control and Prevention. Tuberculosis (TB) and HIV Co‑infection. https://www.cdc.gov/tb/topic/coinsfection/hiv.htm
3. CDC. Treatment of Drug‑Resistant Tuberculosis. https://www.cdc.gov/tb/publications/2023/drt-guidelines.htm
4. Mayo Clinic. Tuberculosis (TB) – Symptoms and causes. https://www.mayoclinic.org/diseases-conditions/tuberculosis/symptoms-causes/syc-20351250
5. Cleveland Clinic. Pott Disease (Spinal Tuberculosis). https://my.clevelandclinic.org/health/diseases/21686-pott-disease-spinal-tuberculosis